Modulation Of The Tumour Microenvironment Using Either Vascular Disrupting Agents or STAT3 Inhibition in Order to Synergise With PD1 Inhibition in Microsatellite Stable, Refractory Colorectal Cancer
- Conditions
- Interventions
- First Posted Date
- 2018-08-27
- Last Posted Date
- 2021-08-27
- Lead Sponsor
- Australasian Gastro-Intestinal Trials Group
- Target Recruit Count
- 90
- Registration Number
- NCT03647839
- Locations
- π¦πΊ
Eastern Health, Box Hill, Victoria, Australia
π¦πΊWestmead Hospital, Westmead, New South Wales, Australia
π¦πΊBallarat Health Service, Ballarat, Victoria, Australia
A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer
- First Posted Date
- 2016-05-16
- Last Posted Date
- 2022-01-13
- Lead Sponsor
- Australasian Gastro-Intestinal Trials Group
- Target Recruit Count
- 250
- Registration Number
- NCT02773524
- Locations
- πΊπΈ
Mayo Clinic Arizona, Scottsdale, Arizona, United States
πΊπΈBon Secours Cancer Institute, Midlothian, Virginia, United States
π¦πΊCanberra Hospital, Canberra, Australian Capital Territory, Australia
A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST)
- Conditions
- Interventions
- First Posted Date
- 2015-02-19
- Last Posted Date
- 2023-07-07
- Lead Sponsor
- Australasian Gastro-Intestinal Trials Group
- Target Recruit Count
- 78
- Registration Number
- NCT02365441
- Locations
- π¦πΊ
Prince of Wales Hospital, Sydney, New South Wales, Australia
π¦πΊFlinders Medical Centre, Adelaide, South Australia, Australia
π¦πΊSir Charles Gairdner, Perth, Western Australia, Australia
Capecitabine ON Temozolomide Radionuclide Therapy Octreotate Lutetium-177 NeuroEndocrine Tumours Study
- Conditions
- Interventions
- First Posted Date
- 2015-02-09
- Last Posted Date
- 2022-07-05
- Lead Sponsor
- Australasian Gastro-Intestinal Trials Group
- Target Recruit Count
- 75
- Registration Number
- NCT02358356
- Locations
- π¦πΊ
Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
π¦πΊFiona Stanley Hospital, Murdoch, Western Australia, Australia
π¦πΊRoyal North Shore Hospital, St Leonards, New South Wales, Australia
Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma
- Conditions
- Interventions
- First Posted Date
- 2013-08-19
- Last Posted Date
- 2022-04-01
- Lead Sponsor
- Australasian Gastro-Intestinal Trials Group
- Target Recruit Count
- 574
- Registration Number
- NCT01924819
- Locations
- π¦πΊ
Calvary Mater Newcastle, Newcastle, New South Wales, Australia
π¦πΊThe Tweed Hospital, Tweed Heads, New South Wales, Australia
π¦πΊPrincess Alexandra Hospital, Brisbane, Queensland, Australia
The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal Cancer
- Conditions
- First Posted Date
- 2006-02-22
- Last Posted Date
- 2007-08-22
- Lead Sponsor
- Australasian Gastro-Intestinal Trials Group
- Target Recruit Count
- 333
- Registration Number
- NCT00294359
- Locations
- π¦πΊ
Nepean Hospital, Sydney, New South Wales, Australia
π¦πΊNorth Shore Private Hospital, Sydney, New South Wales, Australia
π¦πΊPrince of Wales Hospital, Sydney, New South Wales, Australia